Thomas J. Schuetz's Net Worth

$12.7 Million

Estimate Recalculated Mar 11, 2024 09:13AM EST

Who is Thomas J. Schuetz?

Thomas J. Schuetz has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, Compass Therapeutics, Inc., and Audentes Therapeutics, Inc..

SEC CIK

Thomas J. Schuetz's CIK is 0001591464

Past Insider Trading and Trends

2022 was Thomas J. Schuetz's most active year for acquiring shares with 18 total transactions. Thomas J. Schuetz's most active month to acquire stocks was the month of May. 2016 was Thomas J. Schuetz's most active year for disposing of shares, totalling 12 transactions. Thomas J. Schuetz's most active month to dispose stocks was the month of August. 2020 saw Thomas J. Schuetz paying a total of $487,155.00 for 847,431 shares, this is the most they've acquired in one year. In 2020 Thomas J. Schuetz cashed out on 157,586 shares for a total of $5,381,700.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Relypsa Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-36.21K
$32.00
-$1,158,784.00
0
Sep 1
Form 4
+6.63%
2.25K
—
—
36.21K
Jun 21
Form 4
+757.19%
30K
$13.39
$401,832.00
33.96K
Mar 15
Form 4
-20.15%
-1.00K
$34.57
-$34,571.00
3.96K
Scheduled
Jun 11
Form 4
+82.96%
2.25K
—
—
4.96K
Jun 4
Form 4
∞
2.71K
—
—
2.71K
Jun 19
Form 3
—
0
—
—
0
No matching records found

Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.355

PRESIDENT

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.68%
-44.78K
$1.45
-$64,933.90
6.57M
Feb 8
Form 4
+10.66%
637.5K
$1.93
$1,230,375.00
6.62M
Jan 9
Form 4
-0.73%
-44.02K
$1.50
-$66,037.50
5.98M
Nov 17
Form 4
+0.17%
10K
$3.37
$33,700.00
6.02M
Mar 10
Form 4
+0.33%
20K
$3.98
$79,600.00
6.01M
Feb 27
Form 4
+0.33%
20K
$3.86
$77,200.00
5.99M
Feb 15
Form 4
+9.14%
500K
—
—
5.97M
Feb 8
Form 4
+0.37%
20K
$4.05
$81,000.00
5.47M
Jan 31
Form 4
+0.37%
20K
$4.19
$83,800.00
5.45M
Jan 24
Form 4
+0.18%
10K
$2.32
$23,200.00
5.43M
Sep 28
Form 4
+0.28%
15K
$2.27
$34,050.00
5.42M
Sep 26
Form 4
+0.28%
15K
$3.03
$45,450.00
5.41M
Sep 7
Form 4
+0.28%
15K
$2.83
$42,450.00
5.39M
Sep 1
Form 4
+0.28%
15K
$3.05
$45,750.00
5.38M
Aug 17
Form 4
+0.28%
15K
$2.64
$39,600.00
5.36M
Aug 10
Form 4
+0.28%
15K
$2.58
$38,700.00
5.35M
Aug 1
Form 4
+0.38%
20K
$2.80
$56,000.00
5.33M
Jun 21
Form 4
+0.38%
20K
$2.34
$46,800.00
5.31M
Jun 16
Form 4
+0.57%
30K
$2.29
$68,700.00
5.29M
Jun 13
Form 4
+0.57%
30K
$2.83
$84,900.00
5.26M
Jun 6
Form 4
+0.38%
20K
$3.03
$60,600.00
5.23M
Jun 1
Form 4
+0.39%
20K
$3.04
$60,800.00
5.21M
May 26
Form 4
+0.35%
18.36K
$2.72
$49,925.60
5.19M
May 23
Form 4
+0.39%
20.21K
$2.47
$49,931.05
5.17M
May 17
Form 4
+0.54%
27.84K
$1.80
$50,104.80
5.15M
May 10
Form 4/A
—
0
—
—
0
Feb 18
Form 4
—
0
—
—
0
Feb 17
Form 4
+13.26%
600K
—
—
5.13M
Nov 16
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Aug 6
Form 4
+2.20%
97.43K
$5.00
$487,155.00
4.53M
Jun 19
Form 3
—
0
—
—
0
No matching records found

Audentes Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-89.69K
$60.00
-$5,381,700.00
0
Jan 15
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Oct 8
Form 4
—
0
—
—
0
Aug 24
Form 3
—
0
—
—
0
No matching records found